HLS Therapeutics Inc T.HLS

Alternate Symbol(s): HLTRF

HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally. The company’s lead products include Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds royalty interest in Takeda’s Obizur, which is a porcine recombinant Factor VIII for acquired Hemophilia A. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.

TSX:HLS - Post by User

HLS Therapeutics Inc

<< Previous

Bullboard Posts

Next >>

(72)
•••

Comment by wannabebuffeton Mar 17, 2021 5:35pm

359 Views

Post# 32819454

RE:Q FOUR tomorrow before sunrise!

I was tempted to move out of my position into something else but with the predictions of the analysts I decided to stay in. It has made me a lot of money over the years so a few more to see how Vascepa plays out is a good plan. If Vascepa does as planned when rolled out in Canada I would think there would be a lot of US folks looking for a source.

<< Previous

Bullboard Posts

Next >>

The 5-Minute Investor Podcast, Ep. 48: Dazzling solar stocks